OXIGENE INC 4
4 · OXIGENE INC · Filed Jan 6, 2014
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-01-02+4,880→ 4,880 totalExercise: $2.79From: 2014-01-02Exp: 2020-01-02→ Common Stock (4,880 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Director services to be provided through the first six months of 2014.
- [F2]The Stock Options were fully vested as of the grant date.